Company News

Startup Generator is the space reserved at Biocat for interviews and reports on startups linked to the bioscience and biotechnology sector. In this interview, Gisela Lorente, Chief Scientific Officer (CSO), explains the need for a good team, the strategic decisions Aptadel Therapeutics has made, and the importance of being motivated and believing in it. She also reveals …

Dr. Gisela Lorente, CSO at Aptadel Therapeutics, has been interviewed by Biocat Read More »

2021 Richi Entrepreneurs Boston Immersion Program organized by the RichiFoundation has started this week with a selection of the best start ups in the Spanish Innovation Ecosystem. Aptadel Therapeutics has been presenting its next generation developing therapies for curing childhood and adult cancers at the CIC (Cambridge Innovation Center) in Boston. After 2 weeks of …

Aptadel Therapeutics has participated in the 2021 Richi Entrepreneurs Boston Immersion Program. Read More »

Aptadel has been one of the 11 start up selected in the BCN Health Booster programme aimed at companies in the health sector to be accelerated by accessing a laboratory in the Parc Científic de Barcelona. Today our scientific advisor Oscar Martinez Tirado and our CSO Gisela Lorente have participated in the award ceremony lead by Ajuntament de Barcelona, …

Aptadel has been one of the 11 start up selected in the BCN Health Booster programme. Read More »

Aptadel Therapeutics, a pre-clinical biomedical company focused on developing a RNA-based platform of targeted therapy delivery to treat cancer, announces the closing of a $2.1M in seed financing. As part of its expansion strategy, the company has also just established its headquarters at the Barcelona Science Park. Aptadel Therapeutics, founded by Dr Oscar Martinez-Tirado of the Bellvitge …

Aptadel Therapeutics settles in the Barcelona Science Park and raises $2.1M in Seed Financing Round. Read More »